These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 26390360)

  • 1. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.
    Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J
    Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.
    Eckman MH; Wise RE; Naylor K; Arduser L; Lip GY; Kissela B; Flaherty M; Kleindorfer D; Khan F; Schauer DP; Kues J; Costea A
    Curr Med Res Opin; 2015 Apr; 31(4):603-14. PubMed ID: 25690491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision aids for shared decision-making and appropriate anticoagulation therapy in patients with atrial fibrillation: a systematic review and meta-analysis.
    Song D; Zhou J; Fan T; Chang J; Qiu Y; Zhuang Z; Ma J; Zeng L
    Eur J Cardiovasc Nurs; 2022 Mar; 21(2):97-106. PubMed ID: 34550376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Web-based education resources informing patients about stroke prevention in atrial fibrillation.
    Pandya E; Bajorek BV
    J Clin Pharm Ther; 2016 Dec; 41(6):667-676. PubMed ID: 27704588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS; Lip GY
    Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review.
    Wilke T; Bauer S; Mueller S; Kohlmann T; Bauersachs R
    Patient; 2017 Feb; 10(1):17-37. PubMed ID: 27461276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Appropriateness of Oral Anticoagulation for Atrial Fibrillation in Advanced Frailty: Use of Stroke and Bleeding Risk-Prediction Models.
    O'Caoimh R; Igras E; Ramesh A; Power B; O'Connor K; Liston R
    J Frailty Aging; 2017; 6(1):46-52. PubMed ID: 28244558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.
    McGrath ER; Go AS; Chang Y; Borowsky LH; Fang MC; Reynolds K; Singer DE
    J Am Geriatr Soc; 2017 Feb; 65(2):241-248. PubMed ID: 28039855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial.
    Kunneman M; Branda ME; Noseworthy PA; Linzer M; Burnett B; Dick S; Spencer-Bonilla G; Fernandez CA; Gorr H; Wambua M; Keune S; Zeballos-Palacios C; Hargraves I; Shah ND; Montori VM
    Trials; 2017 Sep; 18(1):443. PubMed ID: 28962662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation.
    Thomson R; Robinson A; Greenaway J; Lowe P;
    Qual Saf Health Care; 2002 Mar; 11(1):25-31. PubMed ID: 12078365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Shared Decision-making for Stroke Prevention in Patients With Atrial Fibrillation: A Randomized Clinical Trial.
    Kunneman M; Branda ME; Hargraves IG; Sivly AL; Lee AT; Gorr H; Burnett B; Suzuki T; Jackson EA; Hess E; Linzer M; Brand-McCarthy SR; Brito JP; Noseworthy PA; Montori VM;
    JAMA Intern Med; 2020 Sep; 180(9):1215-1224. PubMed ID: 32897386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
    Noseworthy PA; Yao X; Gersh BJ; Hargraves I; Shah ND; Montori VM
    Int J Cardiol; 2017 Oct; 245():174-177. PubMed ID: 28733071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
    O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a tool to improve the quality of decision making in atrial fibrillation.
    Fraenkel L; Street RL; Fried TR
    BMC Med Inform Decis Mak; 2011 Oct; 11():59. PubMed ID: 21977943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and usability of a mobile health tool on anticoagulation management for patients with atrial fibrillation: a pilot study.
    Zhang C; Pan MM; Wang N; Wang WW; Li Z; Gu ZC; Lin HW
    Eur J Clin Pharmacol; 2022 Feb; 78(2):293-304. PubMed ID: 34671819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.
    Casciano JP; Singer DE; Kwong WJ; Fox ES; Martin BC
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):313-23. PubMed ID: 22920047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological therapy following acute coronary syndromes in patients with atrial fibrillation: how do we balance ischaemic risk with bleeding risk?
    Fake AL; Harding SA; Matsis PP; Larsen PD
    N Z Med J; 2016 May; 129(1435):39-49. PubMed ID: 27355167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitions of care in anticoagulation management for patients with atrial fibrillation.
    Deitelzweig SB
    Hosp Pract (1995); 2012 Oct; 40(4):20-7. PubMed ID: 23299032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Savarese G; Sartipy U; Friberg L; Dahlström U; Lund LH
    Heart; 2018 Jul; 104(13):1093-1100. PubMed ID: 29371374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.